Ralliant Corporation $RAL Holdings Decreased by Aberdeen Group plc

Aberdeen Group plc lowered its stake in Ralliant Corporation (NYSE:RAL) by 62.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 38,792 shares of the company’s stock after selling 65,192 shares during the quarter. Aberdeen Group plc’s holdings in Ralliant were worth $1,661,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the stock. Dodge & Cox acquired a new stake in shares of Ralliant in the 2nd quarter worth approximately $523,571,000. Viking Global Investors LP bought a new stake in Ralliant during the second quarter worth approximately $257,200,000. State Street Corp acquired a new stake in Ralliant in the second quarter worth approximately $213,096,000. Flossbach Von Storch SE boosted its stake in Ralliant by 1.7% during the 3rd quarter. Flossbach Von Storch SE now owns 4,152,866 shares of the company’s stock valued at $181,605,000 after purchasing an additional 67,963 shares in the last quarter. Finally, Norges Bank bought a new position in Ralliant during the 2nd quarter valued at $108,453,000.

Ralliant Trading Down 0.2%

Shares of NYSE RAL opened at $43.69 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38. Ralliant Corporation has a one year low of $37.27 and a one year high of $57.02. The business has a 50-day moving average price of $50.05 and a two-hundred day moving average price of $46.53. The firm has a market capitalization of $4.93 billion and a PE ratio of 22.29.

Ralliant (NYSE:RAL) last issued its earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The company had revenue of $554.60 million for the quarter, compared to analyst estimates of $543.04 million. Ralliant’s quarterly revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Shareholders of record on Monday, March 9th will be paid a $0.05 dividend. The ex-dividend date is Monday, March 9th. This represents a $0.20 dividend on an annualized basis and a yield of 0.5%. Ralliant’s payout ratio is 10.20%.

Analyst Ratings Changes

Several analysts have recently weighed in on RAL shares. Truist Financial cut their price objective on Ralliant from $62.00 to $49.00 and set a “buy” rating for the company in a report on Friday, February 6th. Oppenheimer dropped their price target on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating on the stock in a research report on Friday, February 6th. Morgan Stanley restated an “overweight” rating and set a $45.00 price objective on shares of Ralliant in a research report on Friday, February 6th. Citigroup lowered their price objective on shares of Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Finally, Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 target price on the stock in a report on Friday, February 6th. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Ralliant currently has a consensus rating of “Hold” and an average price target of $50.50.

Insider Transactions at Ralliant

In other news, Director Kevin E. Bryant purchased 1,250 shares of the stock in a transaction that occurred on Friday, February 6th. The stock was acquired at an average price of $39.97 per share, with a total value of $49,962.50. Following the purchase, the director owned 4,653 shares in the company, valued at $185,980.41. This represents a 36.73% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Anelise Angelino Sacks acquired 2,000 shares of the company’s stock in a transaction that occurred on Monday, February 9th. The stock was purchased at an average price of $41.25 per share, for a total transaction of $82,500.00. Following the acquisition, the director directly owned 5,403 shares of the company’s stock, valued at $222,873.75. The trade was a 58.77% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders have bought 8,145 shares of company stock worth $332,233.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.